<p>Roche Holding (OTCMKTS: RHHBY) news for Friday includes an update on coronavirus testing from China.
A press release from Roche Holding reveals that the company has an emergency use permit from the US Food and Drug Administration for its coronavirus test. This test works with RHHBY’s cobas 6800 and cobas 8800 systems.
Roche Holding’s press release states that its test systems are available in many locations around the United States. Because of this, the company says it should be able to perform millions of tests per month for the new coronavirus.
Roche Holding also points out that its machines can quickly give results from seals. It takes about three and a half hours before a test is completed. The systems can post approximately 96 results within a three hour period.
Thomas Schinecker, CEO of Roche Diagnostics, said this about the RHHBY stock.
“In recent weeks, our emergency teams have worked hard to get this test to the patients. CE marking certification and the FDA’s approval of the EUA support our commitment to provide more patients with access to reliable diagnostics that are crucial in combating this serious disease. ”
Roche Holding is not the only company to go ahead with coronavirus testing. OPKO Health (NASDAQ: OPK) also announced today that they are starting testing the virus and working with the New York State Department of Health.
The RHHBY share increased by 7.68% as of Friday afternoon.
At the time of writing, William White had no position in any of the above securities.
© 2020 InvestorPlace Media, LLC